Table of Contents Author Guidelines Submit a Manuscript

Modulation of Lung Immune Response

Call for Papers

In recent decades, considerable progress has been made in the understanding of genetic and immunological factors that contribute to the development and/or treatment of airway disorders. The use of molecular and cellular assays together with knockout animals has contributed significantly to this evolution. Despite this, however, the current therapy for the treatment of airway disorders has not changed to the same degree and is still far from ideal.

In an attempt to respond to this need, one of the areas that have been highlighted most recently is immunology. Knowledge of the participation of the innate and adaptive immune response on the pathophysiological process of infectious and noninfectious airway injuries is rapidly expanding and the advances in the fields of biomedicine and biotechnology have been decisive to this expansion. The innate and adaptive immune system, as well as structural cells, modulates the quantity and quality of airway inflammatory response. Aberrant immune responses, including those induced for allergens, environmental pollutants, infectious agents, acids, and others, promote excessive leukocyte recruitment, production of proinflammatory cytokines, chemokines, and other immunomodulator mediators which are critical to initiate and maintain airway disorders. So, we take a particular interest in manuscripts on the relevance of structural cells, innate and adaptive host responses on modulation/induction, repair, or therapy in the airways. Reviews and original papers that demonstrate the results of clinical, preclinical, or experimental studies of cytokines, antibodies, peptides, RNA interference (RNAi), substances from plants, or other origins that modify immune response for therapeutic purposes are also welcome. In addition, once nanotechnology has a profound impact in many scientific fields and an exponential growth, the impact of colloidal drug delivery systems as carriers for bioactive agents (active substances) in the airways will be interesting. Moreover, papers dealing with detection methods of innate immune parameters in the airways as well as the demonstration of new models to analyze airway disorders would be also interesting. Potential topics include, but are not limited to:

  • The role of innate and adaptive immune system and structural cells on airway disorders
  • The role of cytokines, chemokines, and lipid mediators on airway disorders
  • Infectious lung diseases
  • Modulation of airway inflammation
  • Preclinical and clinical studies of acute and chronic lung inflammation
  • Preclinical and clinical assays evaluating compounds or mediators with the potential to be used in the treatment of airway disorders
  • Identification of natural or synthetic bioactive molecules with potential to be used in the treatment of airway disorders

Before submission authors should carefully read over the journal's Author Guidelines, which are located at Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at according to the following timetable:

Manuscript DueFriday, 3 May 2013
First Round of ReviewsFriday, 26 July 2013
Publication DateFriday, 20 September 2013

Lead Guest Editor

Guest Editors

  • Carlo Jose Freire de Oliveira, Universidade Federal do Tri├óngulo Mineiro, 38025-180, Uberaba, MG, Brazil
  • Edineia Lemos de Andrade, Federal University of Santa Catarina and Reference Centers for Innovative Technologies Foundation (CERTI), 88040-970 Florianopolis, SC, Brazil
  • Oliver Haworth, University of California, Berkeley, CA 94720, USA